Today: 30 April 2026
BP share price rises as oil holds near seven-month highs ahead of US-Iran talks
25 February 2026
1 min read

BP share price rises as oil holds near seven-month highs ahead of US-Iran talks

LONDON, Feb 25, 2026, 08:32 GMT — Regular session

  • BP shares climbed early in London, with crude sticking close to its highest levels in months.
  • Oil prices held steady, with traders on edge as U.S.-Iran negotiations in Geneva loomed for Thursday, Feb. 26.
  • Official U.S. inventory numbers drop later Wednesday, with traders scanning for any signs about demand.

BP stock edged higher in early London hours Wednesday, lifted by stronger crude prices. By 0830 GMT, shares had gained 0.44% to 473.25 pence, trading in a range from 471.20 to 473.55 pence, according to LSE data. The previous close stood at 471.20 pence on Tuesday.

Crude prices hovered close to seven-month peaks, with investors wary of escalating U.S.-Iran tensions before Thursday’s Geneva talks. Brent edged up 0.6% to $71.19 a barrel as of 0730 GMT, and U.S. WTI matched the gain, rising to $66.04. ING strategists flagged that traders would “price in a large risk premium” to guard against possible supply shocks. Iran’s foreign minister Abbas Araqchi called a deal “within reach, but only if diplomacy is given priority.” IG’s Tony Sycamore cited the U.S. “zero enrichment red line” as a hurdle. Attention was also on U.S. Energy Information Administration inventory data due Wednesday, after the American Petroleum Institute posted an 11.43 million-barrel build last week. Reuters

Why does this matter? Oil’s been calling the shots across the sector—not just for BP. According to Reuters, European oil and gas shares surged to a record on Monday, now running about 17% higher for the year. That’s well ahead of the broader STOXX 600 index.

BP tracks Brent much like Shell and TotalEnergies. Its upstream profits and cash flow jump or sink as oil prices shift. When crude moves up, equity traders typically act fast—questions come after.

BP shares remain weighed down by fallout from earlier this month. The company halted its share buyback program and booked roughly $4 billion in writedowns tied to renewables and biogas, according to its Feb. 10 earnings. That hit sent the stock tumbling that day.

Right now, it’s simple: crude prices hover close to recent peaks, so energy stocks are catching renewed attention. Early BP trading showed just moderate volume—investors seem to be holding off for more news.

But here’s the catch: if U.S.-Iran tensions cool off, that geopolitical premium—the extra dollars tacked onto crude over supply concerns—could disappear fast. Oil-related stocks, BP included, may take a hit, regardless of any shift in the company’s daily operations.

Data poses its own risk. If U.S. crude inventories climb sharply again, oversupply fears could intensify, putting the rally’s underlying demand—or its reliance on geopolitical factors—to the test.

Next up: official U.S. inventory numbers hit later Wednesday, Feb. 25, with eyes then turning to Geneva on Thursday, Feb. 26. Crude moves are in focus—BP’s shares are expected to track the action.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Singapore Airlines Q3 profit dives 69% despite record revenue as Air India losses weigh
Previous Story

Singapore Airlines Q3 profit dives 69% despite record revenue as Air India losses weigh

Centrica share price rises as British Gas owner locks in 10-year gas supply deal
Next Story

Centrica share price rises as British Gas owner locks in 10-year gas supply deal

Go toTop